Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
– Firdapse® Q4-20 Net Revenues of $31.0 Million, FY-20 Net Revenues of $119.1 Million –…
Month: March 2021
Longeveron Inc. Announces Partial Exercise of Over-Allotment Option in Initial Public Offering
MIAMI, March 15, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ:LGVN) (“Longeveron” or the “Company”), a…
Rubius Therapeutics Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (NASDAQ: RUBY) (“Rubius”), a…
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia Interim…
Fulgent Genetics Awarded Contract from CDC to Study Variants of COVID-19 Virus
Agreement leverages Fulgent’s Next Generation Sequencing (“NGS”) capabilities for genomic sequencing to aid in ongoing…
Motus GI Announces First Patient Enrolled in a Pilot Study Using the Pure-Vu® System for Patients with Lower GI Bleeding Being Conducted by a Leading U.S. Medical Center
FORT LAUDERDALE, Fla., March 15, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020
Reports Net Revenues of $95.9 Million for the Three Months Ended December 31, 2020 RANCHO…
Tauriga Sciences Inc. Assembles Territorial On-the-Ground Sales Force, Initially Focused on Seven U.S. Cities
03_15_2021 Press Release Image Retail Display Box – Vitamin D3 Infused Tauri-Gum™ The Company’s Assembling of…
Iovance Biotherapeutics Appoints Igor Bilinsky as Chief Operating Officer
SAN CARLOS, Calif., March 15, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates
Total second quarter revenue of $31.5 million increased 62% year-over-year on continued recovery and expansion…
Apabetalone Treatment Prevents COVID-19 Infection of Human Lung Cells
Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral CALGARY, Alberta, March 15, 2021…
BioAegis Therapeutics Completes Recruitment for Phase 2 Clinical Trial of Its Inflammation Regulator, Gelsolin, for COVID-19 Treatment
MORRISTOWN, N.J., March 15, 2021 (GLOBE NEWSWIRE) — BioAegis Therapeutics Inc., a clinical stage, private…
Vistin Pharma ASA: Mandatory notification of trade
Saga Pure ASA has on 15 March 2021 sold 2,284,280 shares in Vistin Pharma ASA,corresponding…
Vistin Pharma ASA: Mandatory notification of trade
Tycoon Industrier AS has today 15 March 2021 purchased 784 280 shares in Vistin Pharma at NOK…
Researchers Unveil a New Theory Explaining Long-term Pain Relief
Stimulation of peripheral nerves warrants consideration early in the care continuum CLEVELAND, March 15, 2021…
Numinus Wellness Inc. Announces Upsized Bought Deal Public Offering to $35 million
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR…
Mersana Therapeutics Announces Publication of Two Manuscripts Detailing Preclinical Studies of the Dolaflexin Platform and Upifitamab Rilsodotin (XMT-1536) in AACR Journal Molecular Cancer Therapeutics
CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage…
KeyedIn Launches Expanded Project Portfolio Management Product Line with Three Editions
MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) — KeyedIn, a leader in Agile Portfolio Management, today…
KeyedIn Announces Updates to its Project Portfolio Management Solutions to Simplify Agile Adoption and Portfolio-Level Decision-Making
MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) — KeyedIn, a leader in Agile Portfolio Management, today announced…
IBM Sponsors the FAIR Institute to Advance Best Practices in Cyber Risk Management
RESTON, Va., March 15, 2021 (GLOBE NEWSWIRE) — In an agreement announced today, IBM joins…